Clinical Trial Update: Effect of Dapagliflozin in Myocardial Fibrosis and Ventricular Function in Patients With a ST-segment Elevation Myocardial Infarction [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating dapagliflozin for effects on myocardial fibrosis and ventricular function in patients after ST-segment elevation myocardial infa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Heart Failure
• Myocardial Fibrosis
• St-segment Elevation Myocardial Infarction

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: ST-segment Elevation Myocardial Infarction (STEMI), Diabetes Mellitus | Phase 3 | Status: ACTIVE_NOT_RECRUITING